2021
-
Nov.
[OLX703A] Selected as national project
Receives Innovative Pharmaceutical company award
-
Oct.
[GalNAc platform] License and Collaboration Agreement
with Hansoh Pharma (Greater China) -
Aug.
[OLX104C] Patent registered in the US
-
Jun.
Certified as Excellent Corporation R&D Center
Selected as KOSDAQ Rising Star
-
Feb.
Receives KNDA (Korea New Drug Award)
-
Jan.
Establishes subsidiary, mCureX Therapeutics, Inc.